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Highly pathogenic avian influenza virus (HPAIV) and Newcastle disease virus (NDV) are two of the most important
viruses affecting poultry worldwide and produce co-infections especially in areas of the world where both viruses
are endemic; but little is known about the interactions between these two viruses. The objective of this study was
to determine if co-infection with NDV affects HPAIV replication in chickens. Only infections with virulent NDV strains
(mesogenic Pigeon/1984 or velogenic CA/2002), and not a lentogenic NDV strain (LaSota), interfered with the
replication of HPAIV A/chicken/Queretaro/14588-19/95 (H5N2) when the H5N2 was given at a high dose (106.9 EID50)
two days after the NDV inoculation, but despite this interference, mortality was still observed. However, chickens
infected with the less virulent mesogenic NDV Pigeon/1984 strain three days prior to being infected with a lower dose
(105.3–5.5 EID50) of the same or a different HPAIV, A/chicken/Jalisco/CPA-12283-12/2012 (H7N3), had reduced HPAIV
replication and increased survival rates. In conclusion, previous infection of chickens with virulent NDV strains can
reduce HPAIV replication, and consequently disease and mortality. This interference depends on the titer of the viruses
used, the virulence of the NDV, and the timing of the infections. The information obtained from these studies helps to
understand the possible interactions and outcomes of infection (disease and virus shedding) when HPAIV and NDV
co-infect chickens in the field.Introduction
Avian influenza virus (AIV) and Newcastle disease virus
(NDV) affect poultry worldwide and cause important
economic losses [1]. Lower virulence viruses produce
subclinical infections and occasionally upper respiratory
disease and drops in egg production; however, more
virulent forms of these viruses cause high mortality in
poultry. AIV and NDV are single-stranded, negative-
sense RNA viruses. AIVs are type A Orthomyxoviruses
and are classified as low pathogenicity (LP) or high
pathogenicity (HP) viruses based on their virulence in
chickens and the presence of multiple basic amino acids
at the cleavage site of the hemagglutinin precursor* Correspondence: Mary.Pantin-Jackwood@ars.usda.gov
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type-1 viruses (APMV-1), are members of the genus
Avulavirus in the Paramyxoviridae family. NDVs also
vary in the type and severity of the disease they produce,
and different pathotypes, based on their virulence in
chickens and principally determined by the sequences
surrounding the protease cleavage site of the fusion pro-
tein, have been described in poultry [3]. The original
classification of NDV isolates into 1 of 3 virulence groups
by chicken embryo inoculation as virulent (velogenic),
moderately virulent (mesogenic), or as low virulence (len-
togenic) has been recently modified for regulatory
purposes. Velogenic and mesogenic viruses are now classi-
fied as virulent NDV, the cause of Newcastle disease (ND),
whereas lentogenic viruses are the low virulence NDV
widely used as vaccines [3]. The intracerebral pathogen-
icity index (ICPI) in day-old chicks is used to differentiates article is distributed under the terms of the Creative Commons Attribution 4.0
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virulent mesogenic strains with ICPI values equal to or
greater than 0.7 and less than 1.5, and velogenic viruses
with ICPI values greater than 1.5. Variant APMV-1 iso-
lates from pigeons, referred to as pigeon paramyxovirus
type 1(PPMV-1), by containing multiple amino acids in
the fusion cleavage site are considered virulent NDV [3].
Virulent NDV isolates, the cause of ND, can spread
rapidly leading to high mortality rates in poultry; the lat-
ter is an especially prominent feature of velogenic (v)
NDV. In the US, and in many countries worldwide, ND
is not endemic and prevention is focused on biosecurity
and the vaccination of poultry with both live and inacti-
vated NDV vaccines [3]. In order to control ND, inten-
sive vaccination programs have been established in
different countries around the world. The most widely
used vaccines are formulated with NDV strains of low
virulence, such as B1 and LaSota [3]. Some countries,
usually those with endemic virulent NDV, use live meso-
genic (m) NDV vaccines as booster vaccines [4-6]; but
these mNDV are considered by the World Organization
for Animal Health (OIE) to be virulent and therefore re-
portable for the purposes of trade if isolated from
poultry [3]. HPAI is also a devastating disease for poultry
and strategies for its control differ depending on the
country, resources, subtype of the virus, and risk to pub-
lic health. Eradication is the main goal, but has not been
a realistic option for all countries, where vaccination
may be considered as the only feasible option [7]. The
current vaccines most commonly used are inactivated
whole virus vaccines, but vectored vaccine use is in-
creasing [8].
Little is known on the interactions between NDV and
AIV when simultaneously infecting poultry. Co-infection of
poultry with more than one etiologic agent is common and
has resulted in increased clinical signs when compared to
single agent infections [9-14]. Conversely, infection of a
host with one virus may affect infection by a second virus,
a phenomenon known as viral interference [15]. Exposure
to NDV, either live vaccines or field strains, is almost
unavoidable for commercial and non-commercial poultry
worldwide, so co-infections with HPAIV are expected to
occur in outbreaks and endemic situations. It is not clear if
co-infections will exacerbate clinical signs of disease or if
viral interference might occur and consequently mask or
affect infections by one or other virus. AIV and NDV co-
infections have been studied using cell cultures or chicken
embryos, with interference between these viruses being re-
ported, one virus inhibiting the growth of the other [16-19];
however, the mechanisms involved in such interference re-
mains to be elucidated. In vivo studies examining AIV and
NDV co-infections are scarce. A study using mallard ducks
showed that co-infection with lentogenic (l) NDV and
LPAIV did not affect the ability of ducks to becomeinfected with either virus and had a minimal effect on viral
shedding [20]. On the other hand, we found that co-
infection of chickens and turkeys with a lNDV and a LPAIV
affected the replication dynamics of these viruses, especially
if given sequentially [21]. Similarly, a reduction of virus
shedding and transmission was found in Pekin ducks co-
infected with a vNDV and a LPAIV, and an increase in
mean death time was observed in ducks infected with
vNDV followed by a HPAIV compared to ducks infected
only with HPAIV [22].
AIV’s are a continuous threat to poultry and public
health worldwide. In order to control AI, it’s important to
understand the pathogenesis of AIV’s in field conditions,
and this includes co-infections with other viruses. The ob-
jective of this study was to determine if co-infection of
chickens with NDV strains of different virulence could
affect the outcome of infection with HPAIV’s. For this, we
conducted experiments to examine the effect of simultan-
eous or sequential infection of chickens with lentogenic,
and virulent (mesogenic and velogenic) NDV strains on
HPAIV infections. Pathogenesis (clinical signs, lesions),




The following viruses were obtained from the Southeast
Poultry Research Laboratory (SEPRL) repository: low viru-
lent (lentogenic) NDV LaSota/1946 (vaccine strain, ICPI =
0.4), virulent (mesogenic) NDV Pigeon/1984 (ICPI = 1.45),
virulent (velogenic) NDV CA/2002 (ICPI = 1.85); and
HPAIVs viruses A/chicken/Queretaro/14588-1988 (H5N2)
and A/chicken/Jalisco/CPA-12283-12/2012 (H7N3). The
viruses were propagated in specific pathogen free (SPF)
embryonating chicken eggs (ECE), as previously described
[23]. Virus-infected allantoic fluid was diluted in brain
heart infusion (BHI) medium (BD Bioscience, Sparks, MD)
in order to obtain an inoculum with titers of 104 to 107
50% egg infectious dose (EID50) per 0.1 mL/bird. Sham
inoculum was made using non-infected allantoic fluid
from SPF ECE diluted 1:300 in brain heart infusion (BHI)
medium (BD Bioscience, Sparks, MD, USA). The experi-
ments were performed in biosecurity level-3 enhanced
(BSL-3E) facilities in accordance with procedures approved
by the SEPRL's Institutional Biosecurity Committee.
Birds
Specific pathogen free (SPF) white leghorn chickens
were obtained from SEPRL’s in-house flocks. The birds
were housed in self-contained isolation units that were
ventilated under negative pressure with inlet and exhaust
HEPA-filtered air and maintained under continuous
lighting. Feed and water were provided with ad libitum
access. Birds were cared for in accordance to an SEPRL’s
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Experimental design
Three similar experiments were conducted. The first ex-
periment examined the effect of simultaneous or previous
inoculation of chickens with low virulence (lentogenic) (l),
virulent (mesogenic) (m), and virulent (velogenic) (v)
strains of NDV on HPAIV infection. A second experiment
examined the effect of co-infection of chickens with the
same mNDV and HPAIV strains, but the timing and dose
of the HPAIV inoculation were modified. In order to cor-
roborate the results of the second study, a third study fur-
ther examined the effect of co-infection by using the same
mNDV strain and a different HPAIV isolate in chickens at
two different ages.
Study 1
Five-week-old SPF chickens were separated into a con-
trol group and virus-inoculated groups. The control
group contained 12 birds, which were intraocularly (IO)
(conjunctival sac of the right eye) and intranasally (IN)
(choanal cleft) inoculated with 0.1 mL total of sham in-
oculum (group 1). The virus-inoculated groups, each
also containing 12 birds, were inoculated IO and IN with
104.7–6.9EID50 in 0.1 mL of the following viruses: group
2, lNDV strain: LaSota/1946 (106.9EID50); group 3,
mNDV strain: Pigeon/1984 (106.3 EID50); groups 4 and 5,
vNDV strain: CA/2002 (low and high dose: 104.7 or 6.3
EID50); and group 6, HPAIV: A/chicken/Queretaro/
14588-1988 H5N2 (106.9 EID50). When birds were chal-
lenged with two viruses, both viruses were either admin-
istered at the same time (day 0; groups 7–10), or
sequentially (HPAIV given 2 days after the NDVs; groups
11–14). Control groups were only exposed to one virus.
Study 2
Three groups of 12 3-week-old SPF chickens were
inoculated IO and IN with the following: Group 1:
0.1 mL of sham inoculum given at day 0; Group 2:
mNDV (Pigeon/1984) (106 EID50 in 0.1 mL) given at day
0 followed by A/chicken/Queretaro/14588-1988 (H5N2)
(105.3 EID50 in 0.1 mL) given at day 3; and Group 3: A/
chicken/Queretaro/14588-1988 H5N2 (105.3 EID50 in
0.1 mL) given at day 3.
Study 3
Two and 4-week-old SPF chickens were separated into
control groups and virus-inoculated groups. The control
groups contained 6–8 birds, which were IO and IN
inoculated with 0.1 mL of a sham inoculum (groups 1
and 6). The virus-inoculated groups, each containing 12
birds, were inoculated IO and IN with the following vi-
ruses: mNDV (Pigeon/1984) (106 EID50 in 0.1 mL;groups 2 and 7) and HPAIV A/chicken/Jalisco/CPA-
12283-12/2012 (H7N3) (105 EID50 in 0.1 mL; groups 3
and 8). When birds were challenged with two viruses,
the viruses were either administered at the same time
(day 0; groups 4, 9) or sequentially (HPAIV given 3 days
after the mNDV; groups 5, 10).
In all studies, birds were observed for clinical signs of
disease over a 10-day period. Oropharyngeal (OP) and
cloacal (CL) swabs were collected from all birds at days
1 and 2 (Study 1 and 2) or 1 through 7 (Study 3) days
post-inoculation (dpi) to determine virus shedding. Two
birds from each group in Studies 1 and 3 were eutha-
nized at 2 dpi in single and simultaneously inoculated
groups, and 2 days after HPAIV inoculation in sequen-
tially infected groups. Gross lesions were recorded and
tissues were collected in 10% neutral buffered formalin
solution to evaluate microscopic lesions and the extent
of virus replication in tissues by immunohistochemistry
as described previously [24,25]. Portions of lung and
spleen were also stored at −70°C for virus detection.
Birds that stopped eating or drinking, had severe neuro-
logical signs, or remained recumbent were euthanized
and counted dead as for the next day. Birds euthanized
for necropsy, moribund birds, and all birds remaining at
the end of the experiments were euthanized by the intra-
venous (IV) administration of sodium pentobarbital
(100 mg/kg body weight).
Virus titrations
OP and CL swabs were collected in 2 mL of BHI broth
with a final concentration of 10 μg/mL of gentamicin,
100 units/mL of penicillin G, and 56 μg/mL of ampho-
tericin B, and kept frozen at −70°C until processed.
RNA was extracted using the MagMax AI/ND RNA iso-
lation kit (Ambion, Inc. Austin TX, USA). Quantitative
real time RRT-PCR (qRRT-PCR) for AIV and Newcastle
disease virus (NDV) detection was performed as previ-
ously described [26,27] with modifications [21]. qRRT-
PCR reactions targeting the influenza virus M gene [28]
and the NDV M gene [29] were conducted using
AgPath-ID one-step RT-PCR Kit (Ambion, Austin, TX)
and the ABI 7500 Fast Real-Time PCR system (Applied
Biosystem, Calsbad, CA). The RT step conditions for re-
actions were 10 min at 45°C and 95°C for 10 min. The
cycling conditions for AIV were 45 cycles of 15 s, 95°C;
45 s, 60°C; and for NDV were 40 cycles of 10 s, 94°C;
30 s, 56°C; 10 s, 72°C. Virus titers in frozen lung and
spleen samples were determined by weighing, homogen-
izing tissues, and diluting in BHI to a 10% (wt/vol)
concentration. Equal amounts of RNA extracted from
the tissue samples were used in the qRRT-PCR assay
(50 ng/μL). For virus quantification, a standard curve
was established with RNA extracted from dilutions of
the same titrated stock of the challenge virus. Ct
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ted against viral titers. The resulting standard curve had
a high correlation coefficient (r2 > 0.99), and it was used
to convert Ct values to EID50. Results were reported as
EID50/mL or EID50/g equivalents and the lower limit
of detection was was 101.5 EID50/mL for AIV and
101.7 EID50/mL for NDV.
Serology
In study 3, serology was conducted on serum from birds
that survived. Hemagglutination inhibition (HI) assays
were used to quantify antibody responses to virus infec-
tion as previously described [30]. Serum was collected
from birds at 10 dpi (7 dpi from the second virus given
in groups exposed to the viruses sequentially). Titers
were calculated as the highest reciprocal serum dilution
providing complete hemagglutination inhibition. Serum
titers of Log2 3 or lower were considered negative for
antibodies against AIV or NDV.
Statistical analyses
Data were analyzed using Prism v.5.01 software
(GraphPad Software Inc. La Jolla, CA, USA). The survival
rate data was analyzed using the Mantel-Cox Log-Rank
test. Differences in the number of chickens positive for
virus shed in co-infected groups compared to single-
infected were analyzed with Fisher’s exact test (two-tailed).
One-way ANOVA with Bonferroni multiple comparison
analysis was used to evaluate virus titers in swabs. For stat-
istical purposes, all OP and CL swabs and tissues from
which virus was not detected were given a numeric value
of 101.4 EID50/mL for AIV and 10
1.6 EID50/mL for NDV.
These values represent the lowest detectable level of virus
in these samples based on the methods used. Statistical
significance was set at P < 0.05.
Results
Study 1
This study examined the effect of simultaneous or previ-
ous infection of 5-week-old chickens with lNDV, mNDV
and vNDV on HPAIV infection.
Clinical signs and survival
None of the chickens inoculated with sham inoculum
showed clinical signs. Chickens inoculated with lNDV
and mNDV had mild conjunctivitis. All the vNDV and
HPAIV-inoculated birds became severely sick and died
with mean death times (MDT’s) between 1.9 and 5.2 days
(Table 1 and Figure 1). Most of the birds died without
previous overt clinical signs (peracute disease), but some
showed non-specific clinical signs including conjunctiv-
itis, ruffled feathers, lethargy, anorexia, swelling of the
head and prostration, especially those birds infected only
with vNDV, which also survived for longer. Some birdsin the groups that received HPAIV also presented
petechial-to-ecchymotic subcutaneous hemorrhages in
leg shanks, feet and combs. No difference in the pres-
ence of clinical signs was observed between single-
infected and co-infected birds.
Bird survival was compared among groups after single
or simultaneous inoculation of the viruses, and after in-
oculation with HPAIV in groups sequentially infected
with the viruses. All birds inoculated only with lNDV or
mNDV, survived and showed significant differences in
survival when compared with the rest of the groups. Dif-
ferences in survival were also found between single-
infected vNDV groups (CA/2002) depending on the
dose, 104.7or 106.3 EID50, (P < 0.01); MDT was lower
with the higher dose (MDT’s of 4.4 days vs. 5.2 days).
Differences in survival were observed between groups
infected only with the vNDV (low or high dose) and
birds inoculated simultaneously or 2 days later with the
HPAIV (P < 0.0001). Low dose of vNDV increased the
survival of the birds when given HPAIV either simultan-
eously or sequentially, when compared to the group in-
oculated only with HPAIV (P < 0.05), contrary to the
high dose vNDV which did not have that effect.
Simultaneous co-infection with lNDV or mNDV and
HPAIV did not significantly increase the survival of the
birds; however, a significant difference in mean death
time was found when comparing birds sequentially in-
fected with these viruses and HPAIV and birds that re-
ceived only HPAIV (P < 0.01), MDT’s of 2.6 and 3.1
versus 2.0 days.
Viral shedding
OP and CL viral shedding were examined at 1 and 2 dpi
by qRRT-PCR and results are shown in Table 1. To
compare the effect of co-infection with NDV on HPAIV
replication, birds sequentially inoculated with NDV
and HPAIV were evaluated at days 3 and 4 after
NDV inoculation), corresponding to days 1 and 2
after HPAIV inoculation.
NDV was detected in most OP swabs from birds inoc-
ulated only with NDV (l, m or v) or from birds sequen-
tially inoculated with the HPAIV, these later groups
corresponding to 3 and 4 days after NDV inoculation.
Fewer birds were positive for lNDV at 2 dpi (OP and CL
swabs) (P < 0.01), and lower OP NDV titers (P < 0.05) at
1 and 2 dpi, were observed from the group inoculated
simultaneously with HPAIV when compared to the
lNDV single-inoculated group. Similarly, lower numbers
of birds shed mNDV or vNDV (low dose) by the OP
route (P < 0.01) and lower viral titers (P < 0.05) at 2 dpi,
were observed from the groups inoculated simultan-
eously with HPAIV when compared to the single-
inoculated groups. None of the birds inoculated simul-
taneously with the vNDV (low dose) and HPAIV shed
Table 1 Study 1: Mortality, mean death time (MDT), oropharyngeal (OP) and cloacal (CL) virus shedding in chickens inoculated with NDV and HPAIV
Virus Number of dead/
total (MDT)
OP shedding: number of birds shedding/total (Log10 EID50/mL)
a CL shedding: number of birds shedding/total (Log10 EID50/mL)
a
NDV HPAIV NDV HPAIV
1 dpi 2 dpi 1 dpi 2 dpi 1 dpi 2 dpi 1 dpi 2 dpi
lNDV 0/10 10/10 (5.3 ± 0.1)A 10/10 (6.1 ± 0.1)A nd nd 1/10 (1.6)A 5/10 (3.3 ± 0.08)A nd nd
mNDV 0/10 7/10 (2.9 ± 0.4)A 10/10 (3.2 ± 0.1)A nd nd 0/10 (0)A 0/10A nd nd
vNDV low dose 10/10 (5.2) 10/10 (4.4 ± 0.1)A 10/10 (5.9 ± 0.1)A nd nd 0/10 (0)A 8/10 (3.8 ± 0.2)A nd nd
vNDV high dose 10/10 (4.4) 10/10 (3.6 ± 0.1)A 10/10 (6.4 ± 0.1)A nd nd 0/10 (0)A 10/10 (5.2 ± 0.1)A nd nd
HPAIV 10/10 (2.0) nd nd 10/10 (4.6 ± 0.1)A 2/2 (5.7 ± 0.1)A nd nd 8/10 (3.1 ± 0.3)A 2/2 (4.9 ± 0.3)A
lNDV + HPAIV 10/10 (2.3) 9/10 (4 ± 0.1)B 5/10 (4.5 ± 0.1)*B 9/10 (4.6 ± 0.1)A 5/5 (6 ± 0.1)A 0/10 (0)A 0/5B 8/10 (2.7 ± 0.3)A 5/5 5.6 ± 0.2)B
mNDV + HPAIV 10/10 (2.2) 2/10 (1.8 ± 0.04)*A 1/3 (2.2)*B 10/10 (4.2 ± 0.1)A 3/3 (5.9 ± 0.3)A 0/10 (0)A 0/3A 8/10 (2.4 ± 0.2)A 3/3 (5.4 ± 0.03)A
vNDV low dose + HPAIV 10/10 (2.4) 5/10 (4.2 ± 0.2)*A 5/5 (4.7 ± 0.1)B 10/10 (4.5 ± 0.1)A 5/5 (5.8 ± 0.2)A 0/10 (0)A 0/5**B 7/10 (2.5 ± 0.4)A 5/5 (5.5 ± 0.2)A
vNDV high dose + HPAIV 10/10 (2.1) 10/10 (4.6 ± 0.3)B 3/3 (6.3 ± 0.1)A 10/10 (4.3 ± 0.1)A 3/3 (6.4 ± 0.3)A 0/10 (0)A 0/3**B 7/10 (2.5 ± 0.4)A 3/3 (5.5 ± 0.2)A
lNDV + HPAIV 2 days later 10/10 (2.6) 10/10 (3.9 ± 0.1)A 7/7 (6.6 ± 0.2)A 10/10 (4.5 ± 0.2)A 7/7 (5.9 ± 0.2)A 2/10 (2.1 ± 0.01)A 0/7*A 7/10 (2.3 ± 0.4)A 7/7 (5.3 ± 0.04)A
mNDV + HPAIV 2 days later 10/10 (3.1) 7/10 (2.4 ± 0.2)A 7/9 (3.1 ± 0.1)A 10/10 (3.8 ± 0.2)A 9/9 (5.8 ± 0.1)A 4/10 (1.8 ± 0.1)B 5/9 (3.2 ± 0.2)*B 10/10 (3.1)A 9/9 (5.2 ± 0.04)A
vNDV low + HPAIV 2 days later 10/10 (2.5) 10/10 (6.4 ± 0.1)B 7/7 (7.6 ± 0.1)B 3/10 (1.5 ± 0.7)**B 7/7 (5.3 ± 0.1)A 10/10 (5.5 ± 0.1)***B 7/7 (7.1 ± 0.1)B 0/10***B 7/7 (5.3 ± 0.05)A
vNDV high + HPAIV 2 days later 10/10 (1.9) 10/10 (6.8 ± 0.1)B 2/2 (8.0 ± 0.3)B 3/10 (2.1 ± 0.1)**B 2/2 (5.3 ± 0.1)A 10/10 (6.3 ± 0.1)***B 2/2 (7.6 ± 0.3)B 0/10***B 2/2 (5.3 ± 0.05)A
For groups inoculated sequentially with the viruses, HPAIV titers are from 1 or 2 days after HPAIV inoculation, which corresponds to days 3 and 4 after NDV inoculation.
aViral titers average ± SEM (standard error mean) from the positive birds; Log10 EID50 equivalents were determined by qRRT-PCR. nd = not done.
*Significant difference in number of chickens virus positive compared to
single virus infected groups (*P < 0.01; **P < 0.001; ***P < 0.0001).












Figure 1 Survival curves after inoculation of chickens with NDV and HPAI viruses (Study 1). Chickens were inoculated simultaneously or
sequentially with different strains of NDV and with HPAIV. Survival curves for chickens inoculated with lNDV and HPAIV (A), mNDV and HPAIV, and
(B) vNDV and HPAIV (C).
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single-inoculated group where 8 of 10 birds shed virus at
this time point. All birds simultaneously inoculated with
the high-dose vNDV and HPAIV shed virus by the OProute at 1 and 2 dpi, and higher OP titers were found at
1 dpi in the co-inoculated groups versus the single
vNDV inoculated group (P < 0.05). However, birds in the
simultaneously inoculated group did not shed virus by
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virus by this route in the single virus inoculated group.
The number of birds shedding HPAIV by the OP and
CL route, and the titers of virus shed, were similar at both
1 and 2 dpi among groups inoculated only with HPAIV
and groups simultaneously co-infected with NDV, with
the exception of birds co-inoculated with lNDV which
shed higher titers of HPAIV by the CL route (P < 0.05).
Similarly, no difference in the number of birds shedding
virus by the OP route was found between birds sequen-
tially inoculated with lNDV or mNDV and HPAIV com-
pared to HPAIV only inoculated birds.
Strikingly, all birds inoculated with vNDV (low and
high dose) then sequentially inoculated with HPAIV,
showed a reduction in the number of birds shedding
HPAIV by the OP and CL routes (P < 0.001; P < 0.0001),
and a reduction of viral titers (P < 0.05) when examined
at 1 dpi, indicating that HPAIV replication was ham-
pered by vNDV. However, this effect was short-lived
since no difference between sequentially inoculated and
single-virus-inoculated groups was observed as of 2 dpi
and beyond.
Gross, microscopic lesions and viral antigen staining in
tissues
Two birds from each group were necropsied 2 dpi (or
2 days after inoculation with HPAIV in the groups that re-
ceived the viruses sequentially). No gross lesions were ob-
served at 2 dpi in chickens inoculated with the sham
inoculum. Mild sinusitis and conjunctivitis were present in
all birds inoculated with lNDV or the mNDV. Chickens in-
oculated with the vNDV had severe sinusitis, edema and
hemorrhages in eyelids, and enlarged mottled spleens. Birds
infected with HPAIV, regardless of exposure to NDV, had
sinusitis, hemorrhages on serosal surfaces of internal or-
gans, especially in the coronary fat and on the epicardium,
within the pectoral muscles and in the cecal tonsils and
Meckel’s diverticulum; swollen kidneys; enlarged mottled
spleens; and malacic brains. Lesions were slightly more
severe in birds simultaneously inoculated with vNDV and
HPAIV.
Microscopic lesions in chickens inoculated with lNDV
and mNDV were confined to the sites of virus inocula-
tion and included mild catarrhal rhinitis, sinusitis, and
mild edema of the eyelid. By contrast, more severe and
widespread histopathological findings were seen with
vNDV and HPAIV infections, consistent with previous
descriptions [24,31].
Viral antigen was present in several organs of birds
inoculated with mNDV, vNDV or HPAIV, suggesting
systemic infection with all three viruses (Additional
files 1 and 2, Figure 2). In birds inoculated with
NDV, NDV-nucleoprotein (NDV-NP) antigen staining
was intracytoplasmic. The tissues with the strongeststaining were; the nasal cavity, eyelids, and lymphoid
organs, similar to previously described [24]. In birds
inoculated with the HPAIV, AIV-nucleoprotein (AIV-
NP) antigen was detected intranuclear and intracyto-
plasmic in blood vessel endothelial cells throughout
the body, and in various cell types within areas of
necrosis and inflammation in many tissues including
nasal cavity, lymphoid tissues, lung, brain, liver, and
spleen, similar lo previously described [31]. Specific-
ally, virus antigen was present in parenchymal cells
of some organs including nasal epithelium, cardiac
myocytes, Kupffer cells, hepatocytes, microglial cells
and neurons, respiratory epithelial cells in the lung,
and tubular epithelial and glomerular cells of the
kidney.
Compared to single-virus infected birds, tissues from
birds simultaneously infected with lNDV and HPAIV
showed more widespread AIV-NP antigen staining. Sim-
ultaneous co-infection with mNDV and HPAIV and low
dose vNDV and HPAIV showed no differences in
HPAIV-NP antigen staining compared with single-virus
infected birds; however, in birds simultaneously co-
infected with high dose vNDV and HPAIV there was
widespread NDV-NP and AIV-NP antigen staining in
tissues. Regarding birds sequentially infected with the
lNDV and HPAIV, and taking into account that tissues
were examined 2 dpi after HPAIV inoculation (4 dpi for
NDV), an enhanced AIV-NP antigen staining was ob-
served when compared to birds infected only with
HPAIV. Widespread AIV-NP antigen staining was found
both in spleen and lung (Figure 2). In birds simultan-
eously infected with mNDV and HPAIV, AIV-NP antigen
staining was less widespread than in birds infected only
with HPAIV alone. Interestingly, in birds sequentially
infected with vNDV (low and high dose) and HPAIV,
AIV-NP antigen staining in tissues was minimal and
NDV-NP widespread (Figure 2).
Virus titers in lung and spleen
Viral titers were determined in lungs and spleens col-
lected from 2 birds per group at 2 dpi (Additional file 3).
NDV viral titers were under the limit of detection in
tissues from lNDV and mNDV single-inoculated and
simultaneously inoculated birds. Low to moderate NDV
virus titers were present in the lungs and spleens
of chickens inoculated with vNDV given single or co-
infected simultaneously with HPAIV (2–4 log10 EID50/
gr); but NDV titers in spleen and lung were under the
limit of detection in birds simultaneously infected with
the low dose of vNDV and HPAIV. NDV titers were
higher in the sequentially inoculated groups because it
corresponded to 4 dpi after NDV inoculation. At this
time, lNDV and mNDV were detected in tissues. High
HPAIV titers were present in both lung and spleen
Figure 2 Immunohistochemical staining for NDV and HPAIV antigens in tissues of co-infected chickens. Viral antigens are stained red.
Spleen and lung from a chicken sequentially inoculated with a low virulence lNDV (LaSota strain) and a HPAIV (A/Ck/Queretaro/14588-19/95
H5N2); tissues collected 2 days after HPAIV inoculation (A and B, lung; C and D spleen). Strong virus staining for HPAIV (A and C) but not for NDV
(B and D). HPAIV antigen staining found in epithelium of air capillaries, mononuclear cells and necrotic debris in lungs, and in mononuclear cells
and necrotic debris in spleen. Spleen and lung from a chicken sequentially inoculated with a virulent vNDV (CA2002 strain) and a HPAIV (A/Ck/
Queretaro/14588-19/95 H5N2); tissues collected 2 days after HPAIV inoculation (E and F, lung; G and H spleen). Strong antigen staining for NDV
(F and H) but not for HPAIV (E and G). NDV antigen staining found in mononuclear cells and necrotic debris in lung and in the histiocytes
surrounding the penicillary arteries in spleen. Magnifications, 400X.
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birds previously infected with vNDV (low or high dose)
had lower HPAIV titers (log10 3.3-4.2 EID50/gr) than the
other HPAIV-inoculated groups (log10 4.4-8.2 EID50/gr).
Study 2
Based on the slight delay of mortality time observed in
the group sequentially infected with mNDV and HPAIV,
and to accentuate the effects of NDV on HPAIV replica-
tion, a study was performed in which 3-week-old chick-
ens were inoculated with the same mNDV (Pigeon 1984)
followed by the same HPAIV (A/chicken/Queretaro/
14588-1988 H5N2) three days later. The one day delay
in the HPAIV challenge allows mNDV pigeon isolate to
achieve more replication as the viral titers typically don’t
reach their peak until 4 dpi. The titer of the HPAIV in-
oculum was also reduced to one log lower (105.3 EID50)
than in the previous experiment to more likely observe
differences between groups. Most birds inoculated with
mNDV were protected against HPAIV disease, with only
1 of 12 birds dying at 8 dpi in the sequential co-infected
group, compared to 11 of 12 birds dying in the group
that received the HPAIV alone (MDT of 3.5 days). In
addition, while all the chickens in the HPAIV-inoculated
group were shedding virus at 2 dpi, only 1 bird out of 12
was positive for HPAIV in the sequentially co-infected
group (data not shown). These results suggested that the
timing of exposure and the titers of the viruses might
affect the outcome of infection.
Study 3
A third experiment was performed to determine if the re-
duction in severity of HPAIV infection in birds previously
infected with mNDV occurs independently of age and
virus strain. Different age chickens (2 and 4-week-old)
were used to compare the effect of immune system matur-
ity on the results of the co-infections. Furthermore a dif-
ferent HPAIV isolate (A/chicken/Jalisco/CPA-12283-12/
2012 H7N3) was used to determine if the protective effect
of mNDV applies to other HPAIV strains. Similar to Study
2, a lower dose of HPAIV was used, and the inoculation of
HPAIV was performed 3 days after inoculation with the
mNDV.
Clinical signs
None of the birds inoculated with sham inoculum
showed clinical signs. Chickens inoculated with the
mNDV had mild conjunctivitis. Six to 8 out of 10 birds
(2 and 4 week-old birds respectively) inoculated only
with HPAIV died, with a MDT of 1.6 days for the
2-week-old chickens and 3.5 days for the 4-week-old
birds (Tables 2 and 3, Figure 3). Eight of 10 birds died in
the groups that were inoculated simultaneously with the
mNDV and the HPAIV, with MDT’s of 2 or 2.1 days. Ingeneral, chickens inoculated with the HPAIV virus in
these groups in both experiments had similar clinical
signs, including ruffled feathers, lethargy, anorexia and
prostration and some birds presented respiratory distress,
swollen head, and cyanotic comb, wattles and legs. Most
birds died without showing previous clinical signs (peracute
disease). Only 1 or 2 of 10 birds 2 and 4-week-old birds
respectively) died in the groups sequentially inoculated
with the viruses, with a MDT of 7 days for the 2-week-old
birds and 9 for the 4-week-old birds. The surviving birds in
these groups showed no clinical signs.
No significant difference in survival among groups was
found regarding the age of the birds and both behaved
similarly. None of the 2-week and 4-week-old chickens in-
oculated only with mNDV died; thus, they showed statisti-
cally significant differences in survival when compared to
the HPAIV-single-infected birds (2-week-old, P < 0.05; 4-
week old P < 0.001), and those simultaneously co-infected
with HPAIV (2 and 4-week-old, P < 0.001). When HPAIV
was given 3 days after the mNDV, almost all birds survived
and the birds that died had a longer mean death time
when compared to the group that was only inoculated
with the HPAIV (2 and 4-week-old; P < 0.001).
Viral shedding
The number of birds shedding virus by the OP and CL
routes and virus titers at 2, 3, 4, and 7 dpi are shown in
Tables 2 and 3. Birds sequentially co-infected with
mNDV and HPAIV were evaluated at days 5, 6, 7 and 10
of the experiment, corresponding to days 2, 3, 4, and 7
after HPAIV inoculation. All 2-week-old chickens inocu-
lated with mNDV and co-infected or not with HPAIV,
were shedding NDV by the OP route at the time points
examined, and most CL swabs were positive by 3 dpi.
No significant difference in mNDV titers was found in
OP and CL swabs when comparing groups. Some of the
4-week-old birds co-infected with mNDV and HPAIV
were not shedding mNDV but the number of birds shed-
ding was not different than mNDV only-inoculated
birds, with the exception of the group sequentially in-
oculated with the viruses, in which more birds shed
virus by the CL route at 4 dpi and at higher titers.
This difference can be attributed to the fact that
this time point corresponds to day 7 after mNDV
inoculation.
At 2 dpi, both 2 and 4-week-old chickens in the
groups sequentially infected with mNDV and HPAIV
lacked HPAIV OP and CL shedding, significantly lower
than to the groups that only received HPAIV (P <
0.001, P < 0.0001). Furthermore, at 3, 4 and 7 dpi, only
0 to 3 out of 9 or 10 birds from these groups (2 and
4-week-old birds respectively) were shedding HPAIV
by the OP or CL route. In the groups simultaneously
infected with mNDV and HPAIV, there was no significant
Table 2 Study 3: Mortality, mean death time (MDT), and OP virus shedding in 2 and 4 week-old chickens inoculated with mNDV and HPAIV
Age Virus Number of dead/
total (MDT)
OP shedding: number of birds shedding/total (Log10 EID50/mL)
a
NDV HPAIV
2 dpi 3 dpi 4 dpi 7 dpi 2 dpi 3 dpi 4 dpi 7 dpi
2 weeks old HPAIV 6/10 (1.6) nd nd nd nd 5/7 (7.9 ± 3)A 3/4 (1.9 ± 0.4)A 0/4A 0/4A
mNDV - 9/10 (3.7 ± 0.3)A 9/10 (3.7 ± 0.1)A 10/10 (4.3 ± 0.3)A 10/10 (4.8 ± 0.2)A nd nd nd nd
mNDV + HPAIV 8/10 (2) 4/4 (3.3 ± 0.6)A 2/2 (4.1 ± 0.1)A 2/2 (4.5 ± 0.4)A 2/2 (3.8 ± 0.2)A 3/4 (7.3 ± 2.9)A 0/2A 0/2A 0/2A
mNDV +HPAIV 3 days later 2/10 (7.0) 10/10 (3.4 ± 0.3)A 9/10 (3.6 ± 0.3)A 9/9 (3.6 ± 0.3)A 9/9 (4.8 ± 0.2)A 0/10**B 0/10*A 1/9 (4.5)A 1/9 (9.3)A
4 weeks old HPAIV 8/10 (3.5) nd nd nd nd 8/9 (7.1 ± 0.9)A 0/5A 4/4 (3.3 ± 0.8)A 0/2A
mNDV - 10/10 (3.5 ± 0.2)A 8/8 (3.5 ± 0.2)A 8/8 (3.8 ± 0.3)A 8/8 (4.7 ± 0.2)A nd nd nd nd
mNDV + HPAIV 8/10 (2.1) 3/5 (2.7 ± 0.5)A 2/2 (3 ± 0.9)A 2/2 (2.9 ± 0.7)A 2/2 (3.6 ± 0.8)A 3/5 (6.6 ± 1.7)A 0/2A 0/2A 0/2A
mNDV +HPAIV 3 days later 1/10 (9.0) 9/10 (3.9 ± 0.3)A 8/10 (3.4 ± 0.4)A 9/10 (3.5 ± 0.3)A 10/10 (4.5 ± 2.1)A 0/10***B 0/10 A 0/10***A 1/10 (10)A
For groups inoculated sequentially with the viruses, the HPAIV results are 2, 3, 4, and 7 days after H7N3 HPAIV inoculation which corresponds to days 5, 6, 7 and 10 after NDV inoculations.
aViral titers average ± SEM from the positive birds; Log10 EID50 equivalents were determined by qRRT-PCR.
nd = not done.
*Significant difference in number of chickens virus positive compared to single virus infected groups (*P < 0.05; **P < 0.01; ***P < 0.001).












Table 3 Study 3: CL virus shedding in 2 and 4 week-old chickens inoculated with mNDV and HPAIV
Age Virus CL shedding: number of birds shedding/total (Log10 EID50/mL)
a
NDV HPAIV
2 dpi 3 dpi 4 dpi 7 dpi 2 dpi 3 dpi 4 dpi 7 dpi
2 weeks old HPAIV nd nd nd nd 3/7 (9.8 ± 0.6)A 0/4A 0/4A 0/4A
mNDV 0/10A 8/10 (2.8 ± 0.3)A 8/8 (3.6 ± 0.2)A 10/10 (3.6 ± 0.2)A nd nd nd nd
mNDV + HPAIV 0/4A 2/2 (2.1 ± 0.4)A 2/2 (3.7 ± 0.2)A 2/2 (4.5 ± 0.15)A 2/4 (8.5 ± 2.8)A 0/2A 0/2A 0/2A
mNDV + HPAIV
3 days later
1/9 (2.1)A 8/10 (2.9 ± 0.1)A 10/10 (3.9 ± 0.2)A 9/9 (4.3 ± 0.2)A 0/10B 0/10A 3/9 (2.2 ± 0.5)A 1/9 (6.9)A
4 weeks old HPAIV nd nd nd nd 4/9 (8.1 ± 0.8)A 1/5 (5.6)A 1/4 (5.4)A 0/2A
mNDV 0/10 4/8 (1.9 ± 0.1)A 8/8 (2.9 ± 0.1)A 8/8 (3.9 ± 0.1)A nd nd nd nd
mNDV + HPAIV 1/5 (1.8) 1/2 (2.5)A 1/2 (3.2)A 2/2 (3.7 ± 0.3)A 3/5 (8.1 ± 2.5)A 0/2A 0/2A 0/2A
mNDV + HPAIV
3 days later
0/10 5/10 (2.3 ± 0.2)A 10/10 (3.7 ± 0.2)*B 10/10 (4.2 ± 0.2)A 0/10*B 1/10 (1.6)A 0/10A 1/10 (4)A
For groups inoculated sequentially with the viruses, the HPAIV results are 2, 3, 4, and 7 days after HPAIV inoculation which corresponds to days 5, 6, 7 and 10
after NDV inoculations.
aViral titers average ± SEM from the positive birds; Log10 EID50 equivalents were determined by qRRT-PCR.
nd = not done.
*Significant difference in number of chickens virus positive compared to single virus infected groups (* P < 0.05).
A; BDifferent superscript uppercase denote significant difference in virus titers compared to single virus infected groups (P < 0.05).
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HPAIV or the viral titers shed at 2 dpi compared to the
groups that only received HPAIV. However, 4 of 4 4-
week-old birds inoculated only with the HPAIV were still
shedding by the OP route at 4 dpi while none of the co-
infected birds were.Figure 3 Survival curves after inoculation of chickens with mNDV and
Chickens inoculated simultaneously or sequentially with mNDV and with HGross, microscopic lesions and viral antigen staining in
tissues
Two birds from each group were necropsied at day 2 or
2 days after inoculated with the HPAIV in the groups that
got the viruses sequentially. No gross lesions were ob-
served in chickens inoculated with the sham inoculum,HPAIV (Study 3). A. 2-week-old chickens. B. 4-week-old chickens.
PAIV.
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birds inoculated with mNDV or sequentially co-infected
with mNDV and HPAIV. Chickens inoculated only with
HPAIV or co-infected with mNDV and HPAIV simultan-
eously, presented lesions typical of HPAIV infection as de-
scribed in Study 1.
Histopathological findings were consistent with mNDV
and HPAIV infections [3,25]. No or less severe lesions
were observed in the birds sequentially inoculated with
the viruses compared to birds that received only HPAIV
or were inoculated simultaneously with the viruses. Mild
conjunctivitis and sinusitis was present in birds inoculated
only with mNDV. Mild to severe, diffuse catarrhal rhinitis
and mild to moderate tracheitis was present in all birds in-
oculated only with HPAIV or simultaneously inoculated
with mNDV. The rest of the lesions were similar to those
observed in study 1.
By immunohistochemistry, NDV-NP antigen was de-
tected mostly in the nasal cavity, lung, spleen and cecal
tonsils, but also in liver and intestine in birds inoculated
only with mNDV. NDV-NP antigen staining was more
common in tissues from birds co-infected with the
HPAIV, including viral staining in eyelid and trachea
(Additional file 4). Widespread AIV-NP antigen staining
was present in tissues from birds inoculated with the
HPAIV given alone or given simultaneously with mNDV
(Additional file 5). In contrast, AIV-NP staining was lim-
ited to nasal cavity, lung and spleen in birds receiving
the viruses sequentially.
Virus titers in lung and spleen
Viral titers were determined in lungs and spleens col-
lected from the 2 birds per group necropsied at 2 dpi
(Additional file 6). Similar to study 1, HPAIV titers were
generally lower in both lung and spleen in birds sequen-
tially inoculated with mNDV and HPAIV (3.3-5.2 log10
EID50/gr) when compared to groups only receiving
HPAIV (6.2-8.1 log10 EID50/gr).
Serology
HI assays were used to test for antibodies against AIV and
NDV in surviving birds in study 3. Because serum samples
were not taken the same day for single-virus, simultan-
eously and sequentially exposed birds (10 dpi for the first
two and 7 dpi for the second), the level of the HI titers
couldn’t be strictly compared, but antibody titers provided
an alternative method for determining viral infection. All
the surviving chickens seroconverted to mNDV, but not to
HPAIV when exposed, with no differences in titers among
the treatment groups (data not shown).
Discussion
The goal of these studies was to evaluate the effect of
NDV on HPAIV infection in chickens. Our results showedthat the severity of the disease caused by HPAIV, the num-
ber of birds shedding virus and the titers of virus shed can
be reduced by previous infection with virulent strains of
NDV (mNDV and vNDV) if given 2–3 days before HPAIV
challenge.
As expected, single-virus infection with lNDV and
mNDV did not cause disease or death in chickens. The
mNDV isolate used in this study was a pigeon strain
(PPMV-1), which typically cause high mortality in pi-
geons but not in chickens. These viruses can acquire
virulence after multiple passages in chickens [32]. In
contrast, infection with vNDV or HPAIV caused severe
disease and high mortality (60-100%). In study 1, there
were no differences in mortality rates in groups that re-
ceived HPAIV alone and sequentially and simultaneously
infected groups, but increased MDT’s were observed in
groups co-infected with lNDV, mNDV and low dose of
vNDV. In addition, OP and CL HPAIV shedding at 1 dpi
were significantly lower in the sequential vNDV (low or
high dose) and HPAIV-inoculated groups when com-
pared to the group inoculated only with HPAIV or sim-
ultaneously with vNDV and HPAIV. By 2 dpi, the OP
and CL viral shedding were similar in all groups, but
IHC on tissues from sequentially infected groups showed
little or no HPAIV antigen as compared to high levels of
HPAIV antigen in the other groups. This indicates that
although vNDV interfered with initial HPAIV replica-
tion, the HPAIV challenge was sufficiently high to over-
come vNDV interference and killed the chickens, the
vNDV itself killed the chickens, or a combination of
both. In studies 2 and 3, we found that when HPAIV
was given at a lower dose three days after inoculation
with the less virulent NDV (mNDV), bird survival in-
creased and virus shedding decreased. By using this less
virulent NDV strain that also replicates systemically, the
replication of HPAIV was reduced to a point that
allowed the host immune response to control the infec-
tion and prevent death.
These results agree with our previous studies showing
viral interference between less pathogenic forms of NDV
and AIV in chickens and turkeys [21]. In this previous
study, although no differences in clinical signs were ob-
served in chickens, prior exposure to lNDV modified viral
shedding patterns by delaying the LPAIV shedding. In the
present study, lNDV had little effect on HPAIV replica-
tion, failing to stop viral systemic spread and replication
leading to death. Nevertheless, the presence of HPAIV af-
fected lNDV replication when given simultaneously.
In studies 2 and 3, mNDV given 3 days prior to a
lower dose HPAIV challenge interfered with HPAIV rep-
lication protecting chickens against death. mNDV and
vNDV strains have a multi-basic amino acid motif at the
fusion cleavage site and can be cleaved intracellularly by
ubiquitous furin-like proteases found in most host
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often is fatal with vNDV’s. On the other hand, mNDV’s
are less pathogenic, rarely producing neurological dis-
ease, and death only seen in young birds [3]. Both NDV
and AIV have mechanisms to interfere with the host in-
nate immune responses including reduction of the inter-
feron (IFN) response. The V protein of NDV is an IFN
antagonist [34], but this effect appears to be strain
dependent. For instance, the V protein of the mesogenic
Beaudette C strain exhibits a greater antagonistic effect
on IFN induction in vitro than that of the lentogenic
LaSota strain [35]. Interestingly, in the case of the velo-
genic strain CA02, a block of IFN pathways did not
occur at the mRNA level when the chicken immune
response was evaluated by microarray, in fact CA02
elicited a strong immune response in chickens suggest-
ing that the host response itself may contribute to the
pathogenesis of vNDV [36]. The most likely mechanism
for the viral interference observed is that the mNDV
produced a robust IFN response that resulted in block-
ing or greatly reducing HPAIV viral replication in the
sequentially infected birds. In the simultaneously in-
fected birds, the IFN response did not develop in time
to prevent infection, resulting in death of the birds. In
the present study, mNDV might be eliciting a more bal-
anced innate immune response, not as strong as vNDV
but strong enough to activate the IFN pathway and pro-
tect against a second virus infection. In this scenario, al-
though it is known that HPAIV can delay IFN-induced
antiviral responses [37], the overall outcome of HPAIV
infection depends on the early innate immune protec-
tion induced by the mNDV, therefore, the timing of the
previous infection with mNDV might be crucial for pro-
tection against HPAIV infection. Because of strain differ-
ences, the observations presented cannot be generalized
to all mNDV’s and the interfering potential of other
mNDV strains needs to be evaluated.
Age-related susceptibility to disease in birds may be
associated with a maturing immune system. For in-
stance, the expression levels of components involved in
the IFN system appear to increase with age [38]. How-
ever, in this study, 2 and 4-week-old chickens showed
similar survival rates and virus shedding patterns sug-
gesting no difference in immune competency. These re-
sults, although insufficient to completely characterize the
mechanism involved in suppression of viral replication,
might also suggest that, apart from non-specific innate
immune responses induced by the earlier infection, viral
competition for target host cells could also be involved,
this second alternative also needing further study.
The existence of previous viral-host interactions cap-
able of modifying the outcomes of a sequential HPAIV
infection indicates that it may be possible to develop
novel strategies to prevent or reduce mortality inHPAIV-infected naïve birds. In some countries where
ND is endemic, mNDV live vaccine strains are used to
control the disease in poultry [3,39]. Some of these
countries report outbreaks of HPAIV; therefore it’s pos-
sible that co-infections with mNDV occur. If this was
the case, disease and mortality caused by HPAIV could
be curbed by previous infection with mNDV, affecting
the clinical diagnosis and the control of the virus; but, as
mentioned, the effect of mNDV on HPAIV infection is
most likely strain dependent. Vaccination with mNDV
strains to protect against HPAI could be a possible op-
tion in countries where ND is endemic. However, since
virulent strains of NDV are reportable to the OIE, the
use of mNDV vaccines would not be an option in coun-
tries free of ND. Further studies are needed to explore
this unconventional use of live NDV vaccines.
In conclusion, co-infection with NDV and HPAIV can
affect the viral replication dynamics and the disease
caused by these viruses in chickens, but this effect will
depend on the virulence of the viruses involved, the
challenge titer of the viruses and the timing of the co-
infections. The identification of factors that influence a
delay of infection of one virus by another will provide
new insights in the pathogenesis of these viruses, allow-
ing the development of novel ways to control viruses.
Additional files
Additional file 1: Study 1: average distribution of NDV-NP antigen
by IHC. Tissues from chickens inoculated simultaneously or sequentially
with different strains of NDV and with a HPAIV were examined at 2 dpi in
single and simultaneously infected groups and at 2 days after inoculation
with the HPAIV in groups sequentially infected (bird 1/bird 2).
Additional file 2: Study 1: average distribution of AIV-NP antigen
by IHC. Tissues from chickens inoculated simultaneously or sequentially
with different strains of NDV and with a HPAIV were examined at 2 dpi in
single and simultaneously infected groups and at 2 days after inoculation
with the HPAIV in groups sequentially infected (bird 1/bird 2).
Additional file 3: Study 1: comparison of virus titers in lung and
spleen. Tissues taken from 2 birds per group at 2 dpi. For groups
inoculated sequentially with the viruses, HPAIV tissues are 2 days after
HPAIV inoculation which corresponds to 4 days after NDV inoculation
(bird 1/bird 2).
Additional file 4: Study 3: average distribution of NDV-NP antigen
by IHC. Tissues from chickens inoculated simultaneously or sequentially
with mNDV and with a HPAIV. Single and simultaneously infected groups
were analyzed at 2 dpi and at 2 days after inoculation with the HPAIV in
groups sequentially infected (bird 1/bird 2).
Additional file 5: Study 3: average distribution of AIV-NP antigen by
IHC in tissues. Tissues from chickens inoculated simultaneously or
sequentially with mNDV and with a HPAIV were examined. Single and
simultaneously infected groups were analyzed at 2 dpi and at 2 days after
inoculation with the HPAIV in groups sequentially infected (bird 1/bird 2).
Additional file 6: Study 3: comparison of virus titers in lung and
spleen. Tissues taken from 2 birds per group at 2 dpi. For groups
inoculated sequentially with the viruses, HPAIV results are 2 days after
HPAIV inoculation (bird 1/bird 2).
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